$400 Million Deal Leaves California-backed HIV Trial Hanging
A California-financed clinical trial testing a promising stem cell therapy for HIV is up in the air this morning following the purchase of its California backer by an Australian corporation in what could be a more than $400 million deal.
The firm being acquired is Calimmune, which has an $8.3 million award from the California Institute of Regenerative Me…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.